Nissan to lead EC-backed multi-standard rapid charge network project in UK and Ireland
UCR CE-CERT testing of hybrid construction equipment finds reduction in fuel consumption, but increase in NOx emissions

Syngenta reaches commercial agreement with ethanol plant to use Enogen corn; alpha amylase in the kernel

Syngenta in North America has signed a commercial agreement with Arkalon Ethanol, LLC of Liberal, Kan., to begin using corn that features Enogen trait technology. Enogen grain delivers alpha amylase enzyme in the corn kernel, eliminating the need for an ethanol plant to use liquid alpha amylase. The ethanol plant will begin using the new grain following the 2014 corn harvest.

The alpha amylase enzyme helps an ethanol plant significantly reduce the viscosity of its corn mash. This reduction can lead to high levels of solids loading, which directly contributes to increased ethanol yields and throughput, as well as cost savings from reduced natural gas, energy, water and chemical usage.

Arkalon’s sister plant, Bonanza BioEnergy, LLC, is currently wrapping up its first year of contracting with local growers to produce Enogen grain. Syngenta collaborated with Bonanza BioEnergy on a three-month Enogen technology trial that ended in July 2012. A commercial agreement followed in November that same year. Arkalon Ethanol and Bonanza BioEnergy are two of three ethanol plants operated by Conestoga Energy Partners, LLC.

Arkalon Ethanol is currently contracting with local corn farmers to produce Enogen grain in 2014. Growers under contract will deliver their Enogen grain to the ethanol plant following the 2014 harvest and will be paid an average premium of 40 cents per bushel for the grain.

In addition to a recent string of new trial and commercial agreements, Syngenta announced in July a three-year commitment to the renewable fuels industry, where Syngenta will donate $1 for every acre planted with Enogen corn to a renewable fuels advocacy group, beginning with this year’s $65,000 donation to Fuels America.


The comments to this entry are closed.